The mid-range pen delivers 1 mg per dose and contains 4 mg total in 3 mL (same 1.34 mg/mL concentration)
However, do not use semaglutide for weight loss if you have: History of gallbladder disease History of pancreatitis Multiple endocrine neoplasia syndrome type 2 (MEN2) or thyroid cancer Side Effects Common side effects to expect while using semaglutide include: Nausea and vomiting Stomach pain Constipation or diarrhea Gas and bloating Burping Headaches Fatigue Key differences between semaglutide vs
Compared to diet and exercise alone, these drugs are much more effective at helping people lose weight
The medication plan is tailored to the patient after a full evaluation of medical history, weight loss patterns, eating behaviors, and metabolic needs
Retatrutide (LY3437943) is an investigational triple GLP-1, GIP, and glucagon receptor agonist developed by Eli Lilly, with Phase 2 clinical data published in 2023 showing dose-dependent body weight reductions and HbA1c improvements
Do not use GLP-1s if you: Have a personal or family history of certain types of thyroid cancer (e.g., medullary thyroid carcinoma) or multiple endocrine neoplasia type 2 Have had pancreatitis or gallbladder disease unless cleared by your doctor Are pregnant, planning to become pregnant, or breastfeeding Have severe gastrointestinal disease (consult your healthcare provider) Common side effects may include: Nausea, especially during the first few weeks Constipation or diarrhea Fatigue or low energy Mild stomach cramping Temporary decrease in appetite To reduce side effects, your provider will typically start with a low dose and increase gradually